These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11351768)

  • 1. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
    Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M;
    Int J Clin Pract; 2001 Apr; 55(3):162-3. PubMed ID: 11351768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP; Lodder J
    Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
    Chairangsarit P; Sithinamsuwan P; Niyasom S; Udommongkol C; Nidhinandana S; Suwantamee J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S148-54. PubMed ID: 16858953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V; Lemmens R; Fieuws S
    Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC
    MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
    Moonis M; Fisher M
    Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):611-5. PubMed ID: 15030260
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does early high dosage dipyridamole in prevention of secondary stroke induce cardiac events?].
    Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M
    Z Kardiol; 2001 May; 90(5):348-51. PubMed ID: 11452896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
    Schrama E; Eusman JP
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2672; author reply 2672-3. PubMed ID: 17205946
    [No Abstract]   [Full Text] [Related]  

  • 15. [Secondary prevention after stroke. Doubled performs better].
    MMW Fortschr Med; 2003 Nov; 145(46):49. PubMed ID: 14699837
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations.
    Sacco RL; Sivenius J; Diener HC
    Arch Neurol; 2005 Mar; 62(3):403-8. PubMed ID: 15767505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
    Offerhaus L
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2673; author reply 2673-4. PubMed ID: 17205947
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary prevention after stroke. 2 platelet inhibitors are better than one].
    MMW Fortschr Med; 2002 May; 144(19):61. PubMed ID: 12116558
    [No Abstract]   [Full Text] [Related]  

  • 20. Dipyridamole may be used safely in patients with ischaemic heart disease.
    Humphreys DM; Street J; Schumacher H; Bertrand-Hardy JM; Palluk R
    Int J Clin Pract; 2002 Mar; 56(2):121-7. PubMed ID: 11926699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.